Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Treatment and prophylaxis of uncomplicated infections with standard systemic antibiotics are usually successful. However, standard systemic antibiotic therapy alone is frequently unsatisfactory in certain circumstances, such as the presence of a foreign body (FB), necrotic tissue, overwhelming bacte...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Roehrborn, A A, Hansbrough, J F, Gualdoni, B, Kim, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486914/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1752
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!